2.950USD-8.39%Mkt Cap: 336.44M $P/E: —1d ago
Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. It discovers and develops its initial …
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap336.44M $
Enterprise Value100.53M $
Revenue (TTM)618.00K $
Gross Profit-90.64M $
Net Income (TTM)-103.12M $
Revenue/Share0.0080 USD
Last Price2.950 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees163
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.60
PEG—
EV/EBITDA-0.86
EV/Revenue162.67
P/S544.40
P/B0.97
EPS (TTM)-1.41
EPS (Forward)-1.13
52W Range
1.96024% of range6.160
52W High6.160 USD
52W Low1.960 USD
Profitability
Gross Margin0.00%
Oper. Margin-37211.84%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-49.81%
ROA-38.63%
Growth
Revenue Growth-77.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-82.48M $
CapEx (TTM)12.75M $
FCF Margin-9511.61%
FCF Yield-17.47%
Net Debt-266.70M $
Net Debt/EBITDA2.29
Balance Sheet
Debt/Equity0.02
Current Ratio8.74
Quick Ratio8.61
Book Value/Sh3.047 USD
Cash/Share2.376 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJun 17, 2024
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)12.93 USD
Upside (mean)+338.4%
Target Range6.000 USD – 18.00 USD
$6.000+338.4% to mean$18.00
# Analysts15
Ownership
Shares Out.114.05M
Float66.42M
Insiders10.81%
Institutions77.43%
Short Interest
Short Ratio10.0d
Short % Float23.80%
Short % Out.19.93%
Shares Short22.72M
Short (prev mo.)12.76M
Technical
SMA 503.442 (-14.3%)
SMA 2003.589 (-17.8%)
Beta1.75
S&P 52W Chg20.25%
Avg Vol (30d)2.16M
Avg Vol (10d)2.27M
Technical Indicators
RSI (14)40.6
MACD-0.0798
MACD Signal-0.0734
MACD Hist.-0.0064
BB Upper3.660 USD
BB Middle3.176 USD
BB Lower2.692 USD
BB Width30.45%
ATR (14)0.2470 USD
Vol Ratio (20d)0.50x